Progesterone treatment for brain injury: An update

Future Neurology

Volumn 5, Issue 1, 2010, Pages 37-46

  Cekic, Milos ^a   Stein, Donald G ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Functional recovery; Neurosteroids; Progesterone; Traumatic brain injury

Indexed keywords

CALCITRIOL; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MEMBRANE PROGESTERONE RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; PLACEBO; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D;

AGING; BLOOD BRAIN BARRIER; BRAIN EDEMA; CELL DEATH; CELL METABOLISM; CELL SURVIVAL; CLINICAL TRIAL; COGNITION; DRUG DOSE REDUCTION; DRUG EFFICACY; FRONTAL CORTEX; GENOMICS; HUMAN; LIPID PEROXIDATION; MORTALITY; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEOMICS; REVIEW; TRAUMATIC BRAIN INJURY; UNSPECIFIED SIDE EFFECT; UPREGULATION; VITAMIN D DEFICIENCY;

EID: 77949355099     PISSN: 14796708     EISSN: None     Source Type: Journal    
DOI: 10.2217/fnl.09.72     Document Type: Review

References (79)

1. Stein DG: Progesterone in the experimental treatment of central and peripheral nervous system injuries. Future Neurol. 1(4), 429-438 (2006).
2. Wright DW, Kellermann AL, Hertzberg VS et al.: ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med. 49, 391-402 (2007).
3. Xiao G, Wei J, Yan W, Wang W, Lu Z: Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit. Care 12, R61 (2008).
4. Doppenberg EM, Choi SC, Bullock R: Clinical trials in traumatic brain injury: lessons for the future. J. Neurosurg. Anesthesiol. 16, 87-94 (2004).
5. Brinton RD, Thompson RF, Foy MR et al.: Progesterone receptors: form and function in brain. Front. Neuroendocrinol. 29, 313-339 (2008).
6. Schumacher M, Guennoun R, Stein DG, De Nicola AF: Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol. Ther. 116, 77-107 (2007).
7. Singh M, Sumien N, Kyser C, Simpkins JW: Estrogens and progesterone as neuroprotectants: what animal models teach us. Front. Biosci. 13, 1083-1089 (2008).
8. Stein DG, Hurn PD: Effects of sex steroids on damaged neural systems. In: Hormones, Brain and Behavior. 2nd Edition. Pfaff DW, Arnold AP, Etgen AM et al. (Eds). Elsevier, Oxford, UK, 2223-2258 (2009).
9. Stein DG: Progesterone exerts neuroprotective effects after brain injury. Brain Res. Rev. 57, 386-397 (2008).
10. Stein DG, Wright DW, Kellermann AL: Does progesterone have neuroprotective properties? Ann. Emerg. Med. 51, 164-172 (2008).
11. Attella MJ, Nattinville A, Stein DG: Hormonal state affects recovery from frontal cortex lesions in adult female rats. Behav. Neural Biol. 48, 352-367 (1987).
12. Gibson CL, Gray LJ, Bath PM, Murphy SP: Progesterone for the treatment of experimental brain injury; a systematic review. Brain 131, 318-328 (2008).
13. Vandromme M, Melton SM, Kerby JD: Progesterone in traumatic brain injury: time to move on to Phase III trials. Crit. Care 12, 153 (2008).
14. Zygun DA, Kortbeek JB, Fick GH, Laupland KB, Doig CJ: Non-neurologic organ dysfunction in severe traumatic brain injury. Crit. Care Med. 33, 654-660 (2005).
15. Cai W, Zhu Y, Furuya K et al.: Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology 55, 127-138 (2008).
16. Behera MA, Dai Q, Garde R et al.: Progesterone stimulates mitochondrial activity with subsequent inhibition of apoptosis in MCF-10A benign breast epithelial cells. Am. J. Physiol. Endocrinol. Metab. 297, E1089-E1096 (2009).
17. Chen G, Shi J, Ding Y, Yin H, Hang C: Progesterone prevents traumatic brain injury-induced intestinal nuclear factor-κβ activation and proinflammatory cytokines expression in male rats. Med. Inflamm. 2007, 93431 (2007).
18. Hu Z, Li Y, Fang M, Wai MS, Yew DT: Exogenous progesterone: a potential therapeutic candidate in CNS injury and neurodegeneration. Curr. Med. Chem. 16, 1418-1425 (2009).
19. Sayeed I, Wali B, Stein DG: Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor. Neurol. Neurosci. 25, 151-159 (2007).
20. Mani SK: Signaling mechanisms in progesterone-neurotransmitter interactions. Neuroscience 138, 773-781 (2006).
21. Mani SK, Portillo W, Reyna A: Steroid hormone action in the brain: cross-talk between signalling pathways. J. Neuroendocrinol. 21, 243-247 (2009).
22. Labombarda F, Gonzalez SL, Deniselle MC et al.: Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-Dx expression in the rat spinal cord. J. Neurochem. 87, 902-913 (2003).
23. Sayeed I, Parvez S, Winkler-Stuck K et al.: Patch clamp reveals powerful blockade of the mitochondrial permeability transition pore by the D2-receptor agonist pramipexole. FASEB J. 20, 556-558 (2006).
24. Ziegler E, Bodusch M, Song Y et al.: Interaction of androsterone and progesterone with inhibitory ligand-gated ion channels: a patch clamp study. Naunyn Schmiedebergs Arch. Pharmacol. 380, 277-291 (2009).
25. Djebaili M, Guo Q, Pettus EH, Hoffman SW, Stein DG: The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J. Neurotrauma 22, 106-118 (2005).
26. Yao XL, Liu J, Lee E, Ling GS, McCabe JT: Progesterone differentially regulates pro- and anti-apoptotic gene expression in cerebral cortex following traumatic brain injury in rats. J. Neurotrauma 22, 656-668 (2005).
27. Wise PM: Estrogen therapy: does it help or hurt the adult and aging brain? Insights derived from animal models. Neuroscience 138, 831-835 (2006).
28. Guerra-Araiza C, Coyoy-Salgado A, Camacho-Arroyo I: Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain. Brain Res. Bull. 59, 105-109 (2002).
29. You JM, Yun SJ, Nam KN et al.: Mechanism of glucocorticoid-induced oxidative stress in rat hippocampal slice cultures. Can. J. Physiol. Pharmacol. 87, 440-447 (2009).
30. Robertson CL, Puskar A, Hoffman GE et al.: Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats. Exp. Neurol. 197, 235-243 (2006).
31. Roglio I, Bianchi R, Gotti S et al.: Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury. Neuroscience 155, 673-685 (2008).
32. Garay L, Gonzalez Deniselle MC, Gierman L et al.: Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 15, 76-83 (2008).
33. De Nicola AF, Labombarda F, Deniselle MC et al.: Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front. Neuroendocrinol. 30, 173-187 (2009).
34. A receptor-mediated transmission in the hypothalamus: effects on reproductive function. Neuropharmacology 52, 1439-1453 (2007).
35. Pan DS, Liu WG, Yang XF, Cao F: Inhibitory effect of progesterone on inflammatory factors after experimental traumatic brain injury. Biomed. Environ. Sci. 20, 432-438 (2007).
36. Chen G, Shi J, Jin W et al.: Progesterone administration modulates TLRs/NF-κβ signaling pathway in rat brain after cortical contusion. Ann. Clin. Lab. Sci. 38, 65-74 (2008).
37. Chen G, Shi JX, Qi M, Wang HX, Hang CH: Effects of progesterone on intestinal inflammatory response, mucosa structure alterations, and apoptosis following traumatic brain injury in male rats. J. Surg. Res. 147, 92-98 (2008).
38. Chen J, Chopp M, Li Y: Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat. J. Neurol. Sci. 171, 24-30 (1999).
39. A receptors in the hippocampus may mediate some antiseizure effects of progestins. Epilepsy Behav. 6, 320-327 (2005).
40. Quadros PS, Pfau JL, Wagner CK: Distribution of progesterone receptor immunoreactivity in the fetal and neonatal rat forebrain. J. Comp. Neurol. 504, 42-56 (2007).
41. Moorthy K, Sharma D, Basir SF, Baquer NZ: Administration of estradiol and progesterone modulate the activities of antioxidant enzyme and aminotransferases in naturally menopausal rats. Exp. Gerontol. 40, 295-302 (2005).
42. Cutler SM, Cekic M, Miller DM et al.: Progesterone improves acute recovery after traumatic brain injury in the aged rat. J. Neurotrauma 24, 1475-1486 (2007).
43. Guo Q, Sayeed I, Baronne LM et al.: Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp. Neurol. 198, 469-478 (2006).
44. Vanlandingham JW, Cutler SM, Virmani S et al.: The enantiomer of progesterone acts as a molecular neuroprotectant after traumatic brain injury. Neuropharmacology 51, 1078-1085 (2006).
45. Charalampopoulos I, Remboutsika E, Margioris AN, Gravanis A: Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol. Metab. 19, 300-307 (2008).
46. Reddy DS, O'Malley BW, Rogawski MA: Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 48, 14-24 (2005).
47. Reddy DS, Apanites LA: Anesthetic effects of progesterone are undiminished in progesterone receptor knockout mice. Brain Res. 1033, 96-101 (2005).
48. Zheng P: Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog. Neurobiol. 89(2), 134-152 (2009).
49. A receptors. Pharmacol. Ther. 116, 35-57 (2007).
50. Covey DF: ent-Steroids: novel tools for studies of signaling pathways. Steroids 74, 577-585 (2009).
51. Jones LA, Anthony JP, Henriquez FL et al.: Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors. Immunology 125, 59-69 (2008).
52. Hwang JY, Duncan RS, Madry C, Singh M, Koulen P: Progesterone potentiates calcium release through IP3 receptors by an Akt-mediated mechanism in hippocampal neurons. Cell Calcium 45, 233-242 (2009).
53. Viero C, Dayanithi G: Neurosteroids are excitatory in supraoptic neurons but inhibitory in the peripheral nervous system: it is all about oxytocin and progesterone receptors. Prog. Brain Res. 170, 177-192 (2008).
54. Sakamoto H, Ukena K, Kawata M, Tsutsui K: Expression, localization and possible actions of 25-Dx, a membrane-associated putative progesterone-binding protein, in the developing Purkinje cell of the cerebellum: a new insight into the biosynthesis, metabolism and multiple actions of progesterone as a neurosteroid. Cerebellum 7, 18-25 (2008).
55. Guennoun R, Meffre D, Labombarda F et al.: The membrane-associated progesteronebinding protein 25-Dx: expression, cellular localization and up-regulation after brain and spinal cord injuries. Brain Res. Rev. 57, 493-505 (2008).
56. Quadros PS, Schlueter LJ, Wagner CK: Distribution of progesterone receptor immunoreactivity in the midbrain and hindbrain of postnatal rats. Dev. Neurobiol. 68, 1378-1390 (2008).
57. Zhu Y, Hanna RN, Schaaf MJ, Spaink HP, Thomas P: Candidates for membrane progestin receptors - past approaches and future challenges. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 148, 381-389 (2008).
58. Mani S: Progestin receptor subtypes in the brain: the known and the unknown. Endocrinology 149, 2750-2756 (2008).
59. McArthur DL, Chute DJ, Villablanca JP: Moderate and severe traumatic brain injury: epidemiologic, imaging and neuropathologic perspectives. Brain Pathol. 14, 185-194 (2004).
60. Onyszchuk G, He YY, Berman NE, Brooks WM: Detrimental effects of aging on outcome from traumatic brain injury: a behavioral, magnetic resonance imaging, and histological study in mice. J. Neurotrauma 25, 153-171 (2008).
61. Holick MF, Chen TC: Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87, S1080-S1086 (2008).
62. Grant WB: Epidemiology of disease risks in relation to vitamin D insufficiency. Prog. Biophys. Mol. Biol. 92, 65-79 (2006).
63. Corino A, D'Amelio P, Gancia R et al.: Hypovitaminosis D in internal medicine inpatients. Calcif. Tissue Int. 80, 76-80 (2007).
64. Chatfield SM, Brand C, Ebeling PR, Russell DM: Vitamin D deficiency in general medical inpatients in summer and winter. Intern. Med. J. 37, 377-382 (2007).
65. Cekic M, Cutler SM, Vanlandingham JW, Stein DG: Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats. Neurobiol. Aging DOI: 10.1016/j.neurobiolaging.2009.04.017 (2009) (Epub ahead of print).
66. Pape HC, Tsukamoto T, Kobbe P et al.: Assessment of the clinical course with inflammatory parameters. Injury 38, 1358-1364 (2007).
67. Margulies S, Hicks R: Combination therapies for traumatic brain injury: prospective considerations. J. Neurotrauma 26, 925-939 (2009).
68. Cekic M, Sayeed I, Stein DG: Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease. Front. Neuroendocrinol. 30, 158-172 (2009).
69. Atif F, Sayeed I, Ishrat T, Stein DG: Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Mol. Med. 15(9-10), 328-336 (2009).
70. Goss CW, Hoffman SW, Stein DG: Behavioral effects and anatomic correlates after brain injury: a progesterone dose-response study. Pharmacol. Biochem. Behav. 76, 231-242 (2003).
71. Mizwicki MT, Norman AW: The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Sci. Signal. 2(75), re4 (2009).
72. Eloranta JJ, Hiller C, Hausler S, Stieger B, Kullak-Ublick GA: Vitamin D3 and its nuclear receptor increase the expression and activity of the human proton-coupled folate transporter. Mol Pharmacol. 76(5), 1062-1071 (2009).
73. Fernandes de Abreu DA, Eyles D, Féron F: Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology DOI: 10.1016/j.psyneuen.2009.05.023 (2009) (Epub ahead of print).
74. Samuel S, Sitrin MD: Vitamin D's role in cell proliferation and differentiation. Nutr. Rev. 66, S116-S124 (2008).
75. Boyan BD, Schwartz Z: 1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases. Cells Tissues Organs 189, 70-74 (2009).
76. Christakos S, Dhawan P, Benn B et al.: Vitamin D: molecular mechanism of action. Ann. NY Acad. Sci. 1116, 340-348 (2007).
77. Ippolito CJ: Battlefield TBI: blast and aftermath. www.psychiatrictimes. com/display/article/10168/56916 (Accessed October 2009)
78. Centers for Disease Control: What is traumatic brain injury. www.cdc.gov/ncipc/tbi/TBI.htm (Accessed September 2009)
79. ClinicalTrials.gov http://clinicaltrials.gov/ct2/show/NCT00822900?term= progesterone,+TBI&rank=1